These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 22339340)
1. Exploiting the therapeutic potential of microRNAs in human cancer. Cho WC Expert Opin Ther Targets; 2012 Apr; 16(4):345-50. PubMed ID: 22339340 [TBL] [Abstract][Full Text] [Related]
2. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics. Xia H; Hui KM Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA dysregulation in cancer: opportunities for the development of microRNA-based drugs. Nana-Sinkam SP; Croce CM IDrugs; 2010 Dec; 13(12):843-6. PubMed ID: 21154140 [TBL] [Abstract][Full Text] [Related]
4. Modulation of microRNAs for potential cancer therapeutics. Wu W Methods Mol Biol; 2011; 676():59-70. PubMed ID: 20931390 [TBL] [Abstract][Full Text] [Related]
6. MicroRNAs as therapeutic targets and their potential applications in cancer therapy. Cho WC Expert Opin Ther Targets; 2012 Aug; 16(8):747-59. PubMed ID: 22690697 [TBL] [Abstract][Full Text] [Related]
8. Epigenetic alterations of tumor marker microRNAs: towards new cancer therapies. Wei J; Xie L; Taron M; Rosell R; Liu B Drug News Perspect; 2010 Dec; 23(10):655-61. PubMed ID: 21180651 [TBL] [Abstract][Full Text] [Related]
9. Cancer therapy via modulation of micro RNA levels: a promising future. Kota SK; Balasubramanian S Drug Discov Today; 2010 Sep; 15(17-18):733-40. PubMed ID: 20692360 [TBL] [Abstract][Full Text] [Related]
10. Anti-oncomir suppression of tumor phenotypes. Goga A; Benz C Mol Interv; 2007 Aug; 7(4):199-202, 180. PubMed ID: 17827440 [TBL] [Abstract][Full Text] [Related]
11. [Application of microRNAs to Cancer Therapy]. Iguchi H; Ochiya T Gan To Kagaku Ryoho; 2010 Mar; 37(3):389-95. PubMed ID: 20332672 [TBL] [Abstract][Full Text] [Related]
12. MicroRNAs in human cancer: from research to therapy. Negrini M; Ferracin M; Sabbioni S; Croce CM J Cell Sci; 2007 Jun; 120(Pt 11):1833-40. PubMed ID: 17515481 [TBL] [Abstract][Full Text] [Related]
13. MicroRNAs and cancer epigenetics: a macrorevolution. Davalos V; Esteller M Curr Opin Oncol; 2010 Jan; 22(1):35-45. PubMed ID: 19907325 [TBL] [Abstract][Full Text] [Related]
14. MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types. Hummel R; Hussey DJ; Haier J Eur J Cancer; 2010 Jan; 46(2):298-311. PubMed ID: 19948396 [TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice. Giovannetti E; Erozenci A; Smit J; Danesi R; Peters GJ Crit Rev Oncol Hematol; 2012 Feb; 81(2):103-22. PubMed ID: 21546262 [TBL] [Abstract][Full Text] [Related]
16. miRNAs in cancer: approaches, aetiology, diagnostics and therapy. Blenkiron C; Miska EA Hum Mol Genet; 2007 Apr; 16 Spec No 1():R106-13. PubMed ID: 17613543 [TBL] [Abstract][Full Text] [Related]
17. MicroRNAs: novel regulators in the hallmarks of human cancer. Ruan K; Fang X; Ouyang G Cancer Lett; 2009 Nov; 285(2):116-26. PubMed ID: 19464788 [TBL] [Abstract][Full Text] [Related]
18. MicroRNAs as new therapeutic targets and tools in cancer. Gandellini P; Profumo V; Folini M; Zaffaroni N Expert Opin Ther Targets; 2011 Mar; 15(3):265-79. PubMed ID: 21208133 [TBL] [Abstract][Full Text] [Related]
19. [MicroRNAs: novel biomarkers for human cancer]. Bartels CL; Tsongalis GJ Ann Biol Clin (Paris); 2010; 68(3):263-72. PubMed ID: 20478768 [TBL] [Abstract][Full Text] [Related]
20. MicroRNAs: small but potent oncogenes or tumor suppressors. Lee YS; Dutta A Curr Opin Investig Drugs; 2006 Jun; 7(6):560-4. PubMed ID: 16784027 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]